Jay Schmelter
Jay Schmelter
Jay Schmelter is a managing director and co-founder of RiverVest. His focus is investing in the medical device sector. Drawing on his combination of operating, investment banking and venture capital experience, Jay works closely with entrepreneurs as a sounding board and mentor. Before co-founding RiverVest, Jay was with Crescendo Ventures, a global venture capital fund, where he led investments for the firm’s life science division. At Crescendo, Jay was involved with several portfolio companies and founded Salient Surgical Technologies, Inc.

Prior to his transition to venture capital, Jay worked as a medical device research analyst at Piper Jaffray & Co., where he focused on cardiovascular-related medical device stocks. He was also a marketing executive for Medtronic, Inc., where he was responsible for two successful product launches and the marketing activities of two of Medtronic’s U.S. cardiac surgery-related businesses.

Jay is a director of Tryton Medical Inc. and InterVene, Inc. He is a former director of Velocimed, LLC, which was acquired by St. Jude Medical, Lutonix, Inc., acquired by C.R. Bard Inc., IDEV Technologies, Inc., acquired by Abbott Laboratories, Inc., Accumetrics, Inc., acquired by ITC Nexus Holding Company (subsequently renamed Accriva,Inc.) and former chairman of Salient Surgical, Inc., which was acquired by Medtronic, Inc.

Jay received his M.B.A. from the University of Chicago and his B.A. in accounting from Michigan State University.